• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinically occult breast lesions: localization and significance.

作者信息

Rosenberg A L, Schwartz G F, Feig S A, Patchefsky A S

出版信息

Radiology. 1987 Jan;162(1 Pt 1):167-70. doi: 10.1148/radiology.162.1.3024209.

DOI:10.1148/radiology.162.1.3024209
PMID:3024209
Abstract

From early 1974 through September 1985, 927 needle-guided breast biopsies were performed for clinically occult breast lesions. Two hundred and seventy (29%) of these lesions were malignant. This frequency of malignancy was comparable to a 20% frequency in biopsy samples obtained because of clinical (palpable) findings. Of 142 patients with nonpalpable invasive lesions who underwent axillary dissection, 42 (30%) had histologically confirmed axillary metastases. Although these invasive lesions may be clinically occult, they are not inconsequential and demand appropriate treatment. For those patients in this series undergoing mastectomy, the frequency of multicentric cancer in the same breast was 39%. The past 10 years have witnessed a trend in surgical management away from the standard radical or modified radical mastectomy toward limited surgery and radiation therapy for so-called early breast cancer. When planning treatment for these occult lesions, one must consider their biological potential to metastasize as well as their propensity for multicentricity.

摘要

相似文献

1
Clinically occult breast lesions: localization and significance.
Radiology. 1987 Jan;162(1 Pt 1):167-70. doi: 10.1148/radiology.162.1.3024209.
2
Needle localization and surgical management of occult breast lesions.隐匿性乳腺病变的针定位及手术处理
J Natl Med Assoc. 1989 Jun;81(6):633-6.
3
Significance and staging of nonpalpable carcinomas of the breast.乳腺隐匿性癌的意义及分期
Surg Gynecol Obstet. 1988 Jan;166(1):6-10.
4
Multicentricity of non-palpable breast cancer.不可触及性乳腺癌的多中心性。
Cancer. 1980 Jun 15;45(12):2913-6. doi: 10.1002/1097-0142(19800615)45:12<2913::aid-cncr2820451202>3.0.co;2-0.
5
Intraductal carcinoma of the breast.乳腺导管内癌
Surg Gynecol Obstet. 1984 Feb;158(2):105-11.
6
An improved technique for needle localized biopsy of occult lesions of the breast.一种改良的乳腺隐匿性病变针定位活检技术。
Surg Gynecol Obstet. 1993 Jan;176(1):25-9.
7
Occult malignant breast lesions in 114 patients: relationship to age and the presence of microcalcifications.114例隐匿性乳腺恶性病变:与年龄及微钙化的关系
Radiology. 1988 Nov;169(2):321-4. doi: 10.1148/radiology.169.2.2845470.
8
Mammographic guidewire localization of nonpalpable breast lesions.乳腺X线引导丝定位不可触及的乳腺病变
Am Surg. 1991 Jul;57(7):431-3.
9
[Clinical analysis of seven patients with occult breast cancer and literature reviews].7例隐匿性乳腺癌患者的临床分析及文献复习
Ai Zheng. 2002 May;21(5):541-3.
10
The role of mammography in evaluating patients with early carcinoma of the breast for tylectomy and radiation therapy.乳腺钼靶摄影在评估早期乳腺癌患者以进行局部切除和放射治疗中的作用。
Radiology. 1982 Jan;142(1):77-80. doi: 10.1148/radiology.142.1.6273967.

引用本文的文献

1
A Deep Learning Decision Support Tool to Improve Risk Stratification and Reduce Unnecessary Biopsies in BI-RADS 4 Mammograms.一种用于改善风险分层并减少BI-RADS 4类乳腺钼靶检查中不必要活检的深度学习决策支持工具。
Radiol Artif Intell. 2023 Aug 9;5(6):e220259. doi: 10.1148/ryai.220259. eCollection 2023 Nov.
2
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.吲哚菁绿-透明质酸混合物(LuminoMark™)用于不可触及乳腺病变患者定位的疗效和安全性:一项多中心、随机、开放标签、平行3期临床试验。
Front Oncol. 2023 Mar 24;13:1039670. doi: 10.3389/fonc.2023.1039670. eCollection 2023.
3
Breast mass classification on sonographic images on the basis of shape analysis.基于形状分析的超声图像乳腺肿块分类
J Med Ultrason (2001). 2010 Oct;37(4):181-6. doi: 10.1007/s10396-010-0278-3. Epub 2010 Aug 7.
4
Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer.鉴定循环抗细胞角蛋白 8/18 抗体的模拟表位及其在乳腺癌诊断中的应用。
Int J Oncol. 2013 Jan;42(1):65-74. doi: 10.3892/ijo.2012.1679. Epub 2012 Oct 26.
5
Nonpalpable breast lesions: preoperative radiological guidance in radioguided occult lesion localisation (ROLL).触诊阴性乳腺病变:放射性核素导向隐匿性病灶定位术中的术前放射影像学引导(ROLL)。
Radiol Med. 2011 Jun;116(4):564-74. doi: 10.1007/s11547-011-0654-0. Epub 2011 Mar 7.
6
Do serum biomarkers really measure breast cancer?血清生物标志物真的能检测出乳腺癌吗?
BMC Cancer. 2009 May 28;9:164. doi: 10.1186/1471-2407-9-164.
7
The value of ultrasound-guided tattooing localization of nonpalpable breast lesions.超声引导下不可触及乳腺病变纹身定位的价值
Korean J Radiol. 2007 Jul-Aug;8(4):295-301. doi: 10.3348/kjr.2007.8.4.295.
8
Optimized approach to decision fusion of heterogeneous data for breast cancer diagnosis.用于乳腺癌诊断的异构数据决策融合优化方法。
Med Phys. 2006 Aug;33(8):2945-54. doi: 10.1118/1.2208934.
9
Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy.乳腺钼靶检查发现的乳腺病变的立体定向粗针活检可作为手术活检的可行替代方法。
Ann Surg Oncol. 1994 Sep;1(5):363-7. doi: 10.1007/BF02303806.
10
X-ray and ultrasound localization of non-palpable breast lesions and difficulties in management.不可触及乳腺病变的X线和超声定位及管理难点
J R Soc Med. 1987 Nov;80(11):678-80. doi: 10.1177/014107688708001106.